The Journal of Immunology, Vol 152, Issue 10 5070-5076, Copyright © 1994 by American Association of Immunologists

ARTICLES

Lipopolysaccharide LPS-mediated soluble TNF receptor release and TNF receptor expression by monocytes. Role of CD14, LPS binding protein, and bactericidal/permeability-increasing protein

JF Leeuwenberg, MA Dentener and WA Buurman
Department of Surgery, University of Limburg, Maastricht, The Netherlands.

Previously we demonstrated that two soluble(s) tumor necrosis factor receptors, TNF-R55 as well as sTNF-R75, are constitutively released in vitro by monocytes, and that this release was markedly enhanced after activation. Because LPS is an important activator of monocytes, we investigated the effect of LPS on sTNF-R release by monocytes. It was found that release of sTNF-R75, but not (or minimally) release of sTNF- R55, was enhanced after activation with LPS, reaching plateau levels after approximately 2 days. CD14, one of the membrane receptors for LPS, is an intermediate in this process, as shown in experiments using mAb directed against CD14. Under serum-free conditions, LPS-induced sTNF-R75 release was less as compared with release in the presence of serum, suggesting involvement of serum proteins. Addition of LPS binding protein (LBP) enhanced the LPS-induced sTNF-R75 release under serum-free conditions, but had no effect in the presence of serum. On the other hand, bactericidal/permeability-increasing protein (BPI), known to possess LPS neutralizing activity, inhibited LPS-induced sTNF- R75 release. Furthermore, cell surface expression of both types of TNF- R was shown to be controlled by LPS, LBP, and BPI. LPS caused, within 1 h, a complete reduction of TNF-R55 as well as TNF-R75 expression, followed by enhanced re-expression of both receptors after 24 h. The down-modulation of expression was increased by LBP, whereas BPI counteracted the LPS-induced down-regulation. The LPS-enhanced release of sTNF-R75, capable of inactivation of TNF, as well as LPS-induced initial down-modulation of TNF-R expression leading to postulated temporary unresponsiveness to TNF may share in a physiological mechanism to carefully control the effects of TNF.

This article has been cited by other articles:

				C. E Bolton, R. Broekhuizen, A. A Ionescu, L. S Nixon, E. F M Wouters, D. J Shale, and A. M W J Schols Cellular protein breakdown and systemic inflammation are unaffected by pulmonary rehabilitation in COPD Thorax, February 1, 2007; 62(2): 109 - 114. [Abstract] [Full Text] [PDF]

				T Gustot, A Lemmers, E Louis, C Nicaise, E Quertinmont, J Belaiche, S Roland, A Van Gossum, J Deviere, and D Franchimont Profile of soluble cytokine receptors in Crohn's disease Gut, April 1, 2005; 54(4): 488 - 495. [Abstract] [Full Text] [PDF]

				H. Dai, J. Guzman, B. Chen, and U. Costabel Production of Soluble Tumor Necrosis Factor Receptors and Tumor Necrosis Factor-{alpha} by Alveolar Macrophages in Sarcoidosis and Extrinsic Allergic Alveolitis Chest, January 1, 2005; 127(1): 251 - 256. [Abstract] [Full Text] [PDF]

				S. Xanthoulea, M. Pasparakis, S. Kousteni, C. Brakebusch, D. Wallach, J. Bauer, H. Lassmann, and G. Kollias Tumor Necrosis Factor (TNF) Receptor Shedding Controls Thresholds of Innate Immune Activation That Balance Opposing TNF Functions in Infectious and Inflammatory Diseases J. Exp. Med., August 2, 2004; 200(3): 367 - 376. [Abstract] [Full Text] [PDF]

				F. M. H. van Dielen, W. A. Buurman, M. Hadfoune, J. Nijhuis, and J. W. Greve Macrophage Inhibitory Factor, Plasminogen Activator Inhibitor-1, Other Acute Phase Proteins, and Inflammatory Mediators Normalize as a Result of Weight Loss in Morbidly Obese Subjects Treated with Gastric Restrictive Surgery J. Clin. Endocrinol. Metab., August 1, 2004; 89(8): 4062 - 4068. [Abstract] [Full Text] [PDF]

				M. d. J. Arana, M. G. Vallespi, G. Chinea, G. V. Vallespi, I. Rodriguez-Alonso, H. E. Garay, W. A. Buurman, and O. Reyes Inhibition of LPS-responses by synthetic peptides derived from LBP associates with the ability of the peptides to block LBP-LPS interaction Innate Immunity, October 1, 2003; 9(5): 281 - 291. [Abstract] [PDF]

				J. H. Vernooy, M. Kucukaycan, J. A. Jacobs, N. H. Chavannes, W. A. Buurman, M. A. Dentener, and E. F. Wouters Local and Systemic Inflammation in Patients with Chronic Obstructive Pulmonary Disease: Soluble Tumor Necrosis Factor Receptors Are Increased in Sputum Am. J. Respir. Crit. Care Med., November 1, 2002; 166(9): 1218 - 1224. [Abstract] [Full Text] [PDF]

				L. Jin, D. P. Raymond, T. D. Crabtree, S. J. Pelletier, C. W. Houlgrave, T. L. Pruett, and R. G. Sawyer Enhanced Murine Macrophage TNF Receptor Shedding by Cytosine-Guanine Sequences in Oligodeoxynucleotides J. Immunol., November 1, 2000; 165(9): 5153 - 5160. [Abstract] [Full Text] [PDF]

				G. Herbein and W. A. O'brien Tumor Necrosis Factor (TNF)-{alpha} and TNF Receptors in Viral Pathogenesis Experimental Biology and Medicine, March 1, 2000; 223(3): 241 - 257. [Abstract] [Full Text]

				M Noguchi, N Hiwatashi, Z Liu, and T Toyota Secretion imbalance between tumour necrosis factor and its inhibitor in inflammatory bowel disease Gut, August 1, 1998; 43(2): 203 - 209. [Abstract] [Full Text] [PDF]

				H. L. Dickensheets, S. L. Freeman, M. F. Smith Jr, and R. P. Donnelly Interleukin-10 Upregulates Tumor Necrosis Factor Receptor Type-II (p75) Gene Expression in Endotoxin-Stimulated Human Monocytes Blood, November 15, 1997; 90(10): 4162 - 4171. [Abstract] [Full Text] [PDF]

				R. Winzen, S. Kafert, B. P. H. A. Mylius-Spencker, K. Resch, and H. Holtmann Interaction between the mRNA of the 55-kDa Tumor Necrosis Factor Receptor and Cellular Proteins. POSSIBLE INVOLVEMENT IN POST-TRANSCRIPTIONAL REGULATION OF RECEPTOR EXPRESSION J. Biol. Chem., June 7, 1996; 271(23): 13461 - 13467. [Abstract] [Full Text] [PDF]